Inflammatory Bowel Disease Patients Are Frequently Nonadherent to Scheduled Induction and Maintenance Infliximab Therapy: A Canadian Cohort Study | Zendy

Christopher Ma | Zendy; Chad Evaschesen | Zendy; Grenvil Gracias | Zendy; Vivian Huang | Zendy; Darryl K. Fedorak | Zendy; Karen I. Kroeker | Zendy; Levinus A. Dieleman | Zendy; Brendan P. Halloran | Zendy; Richard N. Fedorak | Zendy

Open Access

Inflammatory Bowel Disease Patients Are Frequently Nonadherent to Scheduled Induction and Maintenance Infliximab Therapy: A Canadian Cohort Study

Author(s) -

Christopher Ma,

Chad Evaschesen,

Grenvil Gracias,

Vivian Huang,

Darryl K. Fedorak,

Karen I. Kroeker,

Levinus A. Dieleman,

Brendan P. Halloran,

Richard N. Fedorak

Publication year - 2015

Publication title -

canadian journal of gastroenterology and hepatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.921

H-Index - 65

eISSN - 2291-2797

pISSN - 2291-2789

DOI - 10.1155/2015/378628

Subject(s) - medicine , infliximab , ulcerative colitis , maintenance therapy , regimen , inflammatory bowel disease , interquartile range , surgery , retrospective cohort study , disease , chemotherapy

Adherence to maintenance medication regimens in inflammatory bowel disease patients has traditionally been poor. Although infliximab has demonstrated efficacy in inducing and maintaining disease remission, adherence to regularly scheduled infliximab infusions is required to maintain therapeutic trough drug levels and prevent the development of anti-infliximab antibodies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research